Comparison of the seroconversion rate after primary hepatitis B vaccination and after revaccination of non-responders in full-term infants according to mother's HBsAg seropositivity (original) (raw)

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (39)

  1. Kang HS, Song BC, Ji CX, Kim SY, Kim SK. Serologic markers of hepatitis B virus in pregnant women in Jeju Island. Korean J Hepatol 2004;10:191-6.
  2. Choe BH. The management and treatment of chronic hep- atitis B in Korean children. Korean J Pediatr 2007;50:823-34.
  3. Hepatitis B. In: LK Pickering, ed. Red Book: 2006 Report of the Committee on Infectious Diseases 27th ed. Elk Grove Village, IL: Committee on Infectious Diseases, American Academy of Pediatrics 2006;335-55.
  4. Seo JH. Hepatitis B surface antigen and antibody positive rates of children and adolescents in Jeju. Korean J Hepatol 2003;9:304-14.
  5. Park KS, Lee YS, Lee SG, Hwang JY, Chung WJ, Cho KB, et al. A study on markers of viral hepatitis in adults living in Daegu and Gyungbuk area. Korean J Gastroenterol 2003; 41:473-9.
  6. Jang MK, Lee JY, Lee JH, Kim YB, Kim HY, Lee MS, et al. Seroepidemiology of HBV infection in South Korea, 1995 through 1999. Korean J Intern Med 2001;16:153-9.
  7. Shin BM, Yoo HM, Lee AS, Park SK. Seroprevalence of hepatitis B virus among health care workers in Korea. J Korean Med Sci 2006;21:58-62.
  8. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. Epidemiologi- cal findings of hepatitis B infection based on 1998 national health and nutrition survey in Korea. J Korean Med Sci 2002;17:457-62.
  9. Seo K, Park SK, Kim YT, Park O. The prevalence of HBsAg positive parturients in Korea. Korean J Obstet Gy- necol 2005;48:2119-24.
  10. An YW, Chung EH, Rheem IS. A study of the current (2003-2005) prevalence of anti-HBs and immunologic me- mory of hepatitis B vaccine in children from the central area of Korea. Korean J Pediatr 2006;49:630-4.
  11. Zervou EK, Gatselis NK, Xanthi E, Ziciadis K, Georgiadou SP, Dalekos GN. Intrafamilial spread of hepatitis B virus infection in Greece. Eur J Gastroenterol Hepatol 2005;17:911-5.
  12. Ucmak H, Faruk Kokoglu O, Celik M, Ergun UG. Intrafamilial spread of hepatitis B virus infection in eastern Turkey. Epidemiol Infect 2007;135:1338-43.
  13. Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet 1989;1:889-93.
  14. Deertekin H, Tuzcu A, Yalin K. Horizontal transmission of HBV infection among students in Turkey. Public Health 2000;114:411-2.
  15. Kim YS, Ahn YO. Factors associated with intrafamilial transmission of hepatitis B virus infection in Korea. J Korean Med Sci 1993;8:395-404.
  16. Belloni C, Tinelli C, Orsolini P, Pistorio A, Avanzini A, Moretta A, et al. Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine. Vaccine 1998;16:399-402.
  17. Shivananda, Somani V, Srikanth BS, Mohan M, Kulkarni PS. Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India. Clin Vaccine Immunol 2006;13:661-4.
  18. Kim YD, Han MK, Kim AE, Kim KS, Pi SY. Immune responses of hepatitis B vaccination among very low birth weight infant. Korean J Pediatr 2006;49:857-63.
  19. Hasanjani Roushan MR, Pasha YZ, Saghebi R, Kohi F. Revaccination of non-responding infants delivered by HBsAg-positive mothers. Eur J Clin Microbiol Infect Dis 2005;24:434-5.
  20. Prakash C, Bhatia R, Kumari S, Verghese T, Datta KK. Response to hepatitis B vaccination in high risk population. J Commun Dis 2000;32:17-21.
  21. Lazizi Y, Badur S, Perk Y, Ilter O, Pillot J. Selective unre- sponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA. Vaccine 1997; 15:1095-100.
  22. Hieu NT, Kim KH, Janowicz Z, Timmermans I. Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years. Vaccine 2002;20:1803-8.
  23. Yen YH, Chen CH, Wang JH, Lee CM, Changchien CS, Lu SN. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan). Liver Int 2005;25:1162-8.
  24. Ukena T, Esber H, Bessett R, Parks T, Crocker B, Shaw F. Site of injection and response to hepatitis B vaccine. N Engl J Med 1985;313:579-80.
  25. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis 2002;35:1368-75.
  26. Lau YL, Tam A, Ng KW, Tsoi NS, Lam B, Lam P, et al. Response of preterm infants to hepatitis B vaccine. J Pediatr 1992;121:962-6.
  27. Bock HL, Kruppenbacher J, Snger R, Hbel W, Clemens R, Jilg W. Immunogenicity of a recombinant hepatitis B vaccine in adults. Arch Intern Med 1996;156:2226-31.
  28. Chan W, Petric M, Wang E, Koren G, Read S, Blanchette V. Response to hepatitis B immunization in children with hemophilia: relationship to infection with human immunode- ficiency virus type 1. J Pediatr 1990;117:427-30.
  29. Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, Marcus-Bagley D. The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med 1992;175:495-502.
  30. Jafarzadeh A, Shokri F. The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates. Clin Exp Immunol 2003;131: 451-6.
  31. Jafarzadeh A, Zarei S, Shokri F. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates. Vaccine 2008; 26:269-76.
  32. Zhuang GH, Yan H, Wang XL, Hwang LY, Wu Q, Wang LR, et al. Hepatitis B revaccination in healthy non-responder Chinese children: five-year follow-up of immune response and immunologic memory. Vaccine 2006;24:2186-92.
  33. Kim MJ, Nafziger AN, Harro CD, Keyserling HL, Ramsey KM, Drusano GL, et al. Revaccination of healthy nonre- sponders with hepatitis B vaccine and prediction of seropro- tection response. Vaccine 2003;21:1174-9.
  34. Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007;166:813-8.
  35. Jeong O, Kim JH. The outcome of perinatal prophylaxis for HBeAg positive mothers according to the maternal HBV- DNA levels at the delivery time. Korean J Pediatr 2007;50: 348-54.
  36. Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007;25: 6958-64.
  37. Williams IT, Goldstein ST, Tufa J, Tauillii S, Margolis HS, Mahoney FJ. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J 2003;22:157-63.
  38. Zanetti AR, Mariano A, Romano L, D'Amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005;366:1379-84.
  39. Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, et al. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adoles- cents vaccinated during infancy. Pediatrics 2007;120:e373-81.